This fall, the Journal of Clinical Oncology (JCO) presented two special series: “Pediatric Cancer—Progress Through Collaboration” and “Head and Neck Cancer: Recent Advances, Changing Epidemiology, and Future Directions.”
The Pediatric Special Series highlighted collaborative efforts that have contributed to the remarkable progress achieved in advancing survival for patients with pediatric cancers. The pediatric cancer experience is unique in that it has a high level of clinical trial participation—making it instrumental in establishing effective therapies, characterizing toxicities of therapy, refining treatment approaches, and modifying therapy to prevent adverse treatment-related effects. This Special Series also featured articles on innovative and genomic discoveries that have guided risk-adapted stratification of therapy and the use of targeted therapy in providing real prospects for precision medicine. The Pediatric Special Series was particularly appealing to pediatric, surgical, and radiation oncologists; hospitalists; family physicians; pharmacists; and many others.
The Head and Neck Cancer Special Series aimed to deliver the latest evidence and recommendations for management of mucosal head and neck, nasopharyngeal, and nonmelanoma cutaneous carcinomas. In addition, this series provided timely reviews on varied topics, such as the rapidly evolving data on human papillomavirus-associated oropharyngeal cancer; the significant technologic advances in surgery and radiotherapy; improved understanding of the genomics of head and neck cancers; the exciting prospects of the new immunotherapeutic agents; insights into the management of late toxicities; and survivorship and quality-of-life issues. The goal of the Head and Neck Cancer Special Series was to enhance the understanding of the advances in biology and treatment of head and neck cancer, with a focus on the areas of greatest relevance to practicing clinicians. This Special Series was of particular interest to medical, surgical, and radiation oncology doctors and nurses; radiation therapists; scientists; speech therapists; dietitians; dentists; industry leaders; and epidemiologists.
Highlights From the Journal of Global Oncology’s First Issue
The Journal of Global Oncology (JGO) published its first issue this September. ASCO President Julie Vose, MD, MBA, FASCO, and Immediate Past President Peter Paul Yu, MD, FACP, FASCO, wrote the inaugural editorial, “Building Bridges for Collective Wisdom,” welcoming readers to this online-only open-access journal.
Highlights of this first issue include:
A review by Daniela Stefan, MD: “Cancer Care in Africa: An Overview of Resources”
A special article by Pat Garcia-Gonzalez et al: “A Novel Humanitarian Aid Program, the Glivec International Patient Assistance Program (GIPAP): Lessons Learned from Providing Access to Breakthrough Targeted Oncology Treatment in Low- and Middle-Income Countries (LMICs)”
An original report by Kenneth Cornetta, MD, et al: “Integration of Palliative Care Into Comprehensive Cancer Treatment at Moi Teaching and Referral Hospital in Western Kenya”
An editorial by Shahin Sayed, PhD, et al: “Providing Pathology Support in Low-Income Countries”
Stayed Tuned—New Journal!
ASCO’s board has approved a new journal focusing on clinical cancer informatics. ■
© 2015. American Society of Clinical Oncology. All rights reserved.
